These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4635553)
1. [Changes in the activity of the renin-aldosterone system under the effect of diuretics in patients with circulatory insufficiency]. Speranskaia NV; Kuz'mina AE Kardiologiia; 1972 Feb; 12(2):71-8. PubMed ID: 4635553 [No Abstract] [Full Text] [Related]
7. [Treatment of cardiac patients with furosemide. Effect on hemodynamics, water and electrolyte balance]. Sidorenko BA Munch Med Wochenschr; 1969 Oct; 111(40):2032-7. PubMed ID: 5394863 [No Abstract] [Full Text] [Related]
9. [Clinical effect of a new saluretic drug: ethacrynic acid]. D'Amico G; Romagnoni M; Scatolini G; Piane C; Castelluccio A; Cammi L; Rovelli E Minerva Nefrol; 1968; 15(4):245-52. PubMed ID: 5745813 [No Abstract] [Full Text] [Related]
10. [The use of digoxin, lasix and finoptin in treating circulatory failure in hypertension]. Orynchak MA Ter Arkh; 1989; 61(8):17-21. PubMed ID: 2686070 [TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of bumetanide in the diuretic treatment of heart failure and liver cirrhosis]. Mauro G; Cantino G; Vigiani L Clin Ter; 1981 Mar; 96(5):515-21. PubMed ID: 7285521 [No Abstract] [Full Text] [Related]
12. Physiologic and clincical observations on furosemide and ethacrynic acid. Laragh JH; Cannon PJ; Stason WB; Heinemann HO Ann N Y Acad Sci; 1966 Nov; 139(2):453-65. PubMed ID: 5339515 [No Abstract] [Full Text] [Related]
13. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure. Rademaker MT; Charles CJ; Nicholls MG; Richards AM Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977 [TBL] [Abstract][Full Text] [Related]
14. [Mechanism of the stimulating effect of furosemide, ethacrynic acid and novurit on renin secretion by the kidneys]. Simerzina LV Farmakol Toksikol; 1980; 43(1):78-81. PubMed ID: 6991284 [TBL] [Abstract][Full Text] [Related]
16. [Aldosterone and aldosterone antagonists in surgery]. Oelert H Anaesthesist; 1971 Jun; 20(6):205-11. PubMed ID: 4943021 [No Abstract] [Full Text] [Related]
17. [Hormonal disturbances and the treatment of refractory forms of congestive circulatory insufficiency]. Korochkin IM; Matveeva IV Kardiologiia; 1976 Aug; 16(8):36-43. PubMed ID: 1011503 [TBL] [Abstract][Full Text] [Related]
18. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Bayliss J; Norell M; Canepa-Anson R; Sutton G; Poole-Wilson P Br Heart J; 1987 Jan; 57(1):17-22. PubMed ID: 3541995 [TBL] [Abstract][Full Text] [Related]
19. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782 [TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis. Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]